Haemonetics wins patent infringement case against Fenwal

June 4, 2009 by MassDevice staff

Braintree blood management firm wins nearly $16 million in damages, 10 percent royalties and an injunction against further sales of the Illinois company's Alyx disposable blood collection kits; Fenwal to appeal.

Haemonetics Corp. won a patent infringement suit against Fenwal Inc., which said it plans to appeal the decision.

The ruling, issued in Boston Monday by Judge Nathaniel Gorton of the U.S. District Court, follows a jury's decision that a component of the Lake Zurich, Ill.-based blood management products maker's Alyx blood collection system infringes a patent held by Haemonetics. The jury awarded the Braintree firm $15.7 million in damages for the infringement.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.